Startups
Buzzkill Labs is modernizing drug testing for a world of legal cannabis. We are developing and commercializing portable, rapid, cost-effective testing of oral fluid (saliva) that distinguishes and measures THC parent compound, the psychoactive component of cannabis that causes impairment. Our technology helps to eliminate cheating and to determine current potential impairment versus past use with no interference from CBD or metabolites in 15 minutes.
Overview
Location
United States, California, Livermore
Employees
1-10
Founded date
2018
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 14, 2024 | Buzzkill Labs Launches ToxiTrace™: A Groundbreaking Lab-in-a-Box Solution for Rapid Marijuana Detection | Buzzkill Labs and Colorado Mobile Drug Testing Teams ToxiTrace™ Instrument ToxiTrace™ Rapid Analysis System Logo ToxiTrace™, a groundbreaking platform poised to revolutionize drug testing, offers an automated lab-in-a-box solution for detec... |
| May 17, 2023 | Buzzkill Labs Closes Series A Financing | Buzzkill Labs, a Livermore, CA-based developer of a saliva test for psychoactive THC, raised an undisclosed amount in Series A funding. The round was led by Poseidon and existing investors. Buzzkill also announced the appointment of Patrick... |
Reviews 0
FAQ about Buzzkill Labs
When was Buzzkill Labs founded?
Buzzkill Labs was founded in 2018.
What has the press written about Buzzkill Labs?
Parsers VC has collected 3 articles mentioning Buzzkill Labs, among them “Buzzkill Labs Launches ToxiTrace™: A Groundbreaking Lab-in-a-Box Solution for Rapid Marijuana Detection” (May 14, 2024) and “Buzzkill Labs Closes Series A Financing” (May 17, 2023).
Is Buzzkill Labs still active?
Buzzkill Labs is probably closed: its latest activity on Parsers VC dates from May 21, 2024.